Adam, M., Spin, J. M., Tsao, P. S., Meyer, S., Knors, H., Radunski, U. K., . . . Baldus, S. (2015). Levosimendan displays anti-inflammatory effects and decreases MPO bioavailability in patients with severe heart failure. Scientific Reports, 9704. https://doi.org/10.1038/srep09704
Chicago Style (17th ed.) CitationAdam, Matti, et al. "Levosimendan Displays Anti-inflammatory Effects and Decreases MPO Bioavailability in Patients with Severe Heart Failure." Scientific Reports 2015: 9704. https://doi.org/10.1038/srep09704.
MLA (9th ed.) CitationAdam, Matti, et al. "Levosimendan Displays Anti-inflammatory Effects and Decreases MPO Bioavailability in Patients with Severe Heart Failure." Scientific Reports, 2015, p. 9704, https://doi.org/10.1038/srep09704.